Nucor earnings beat by $0.08, revenue fell short of estimates
LONDON - Reckitt Benckiser Group plc (LSE:LON:RKT) announced changes to its board committee structure on Friday following the departure of Mehmood Khan, who has stepped down as a Non-Executive Director and Chair of the Compliance Committee.
According to the company’s press release, Board Chair Sir Jeremy Darroch has taken the opportunity to review and reorganize committee memberships with immediate effect.
Pat Verduin will now chair the Compliance Committee, with Kris Licht, Stefan Oschmann and Marybeth Hays (LON:HAYS) continuing as members.
The Remuneration Committee will maintain Fiona Dawson as chair, with Jeremy Darroch, Mahesh Madhavan and Stefan Oschmann serving as members.
Andrew Bonfield will continue to chair the Audit Committee, with Elane Stock, Margherita Della Valle, Tamara Ingram and Marybeth Hays remaining as members.
The Nomination Committee structure remains unchanged with Jeremy Darroch as chair, alongside Andrew Bonfield and Margherita Della Valle as members.
Reckitt Benckiser, which owns consumer health and hygiene brands including Dettol, Durex, Lysol and Nurofen, confirmed in its statement that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R.
The company trades on the London Stock Exchange (LON:LSEG) under the name Reckitt, though its formal corporate identity remains Reckitt Benckiser Group plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.